Innova Captab Ltd
Innova Captab Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Overall business growth targeted at 20%+ year-on-year (Vinay Lohariwala, Q3 FY26 call). - Jammu facility expected to drive 20%+ growth for the next 2-3 years with revenues ramping up from Rs. Innova Captab projects a sustained overall growth of 20%+ year-on-year at the organization level, driven significantly by ramp-up at the Jammu facility for the next 2-3 years. - Jammu facility revenues are expected to grow from Rs.
From Innova Captab Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Overall business growth targeted at 20%+ year-on-year (Vinay Lohariwala, Q3 FY26 call).
- Jammu facility expected to drive 20%+ growth for the next 2-3 years with revenues ramping up from Rs. 89 crores in Q3 FY26 towards a potential Rs. 1,400 crores at optimum capacity (Lokesh Bhasin, Vinay Lohariwala).
- Jammu offers significant room for scaling beyond FY28-29, with future growth strategies in development (Vinay Lohariwala).
- Branded generics projected to sustain growth around 20%+ annually over the next 2-3 years, supported by domestic and international expansion (Vinay Lohariwala, Lokesh Bhasin).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Innova Captab Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Innova Captab is focused on ramping up the Jammu facility, which started commercial production in January 2025 and is expected to drive 20%+ overall business growth for the next 2-3 years.
- Jammu facility has potential revenue capacity of Rs. 1,400+ crores at 65-75% utilization.
- The company is actively working on future growth strategies beyond FY28-29 to identify new growth engines and will inform the market once plans are finalized.
- Current operations at Jammu are nearing EBITDA breakeven, with positive contributions expected in FY27.
2 more points management made on capital expenditure plans
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Innova Captab Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Innova Captab Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹448 Cr, net profit ₹38 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Innova Captab's management said in earlier quarters
Others in Pharmaceuticals & Biotechnology this season
- RPG Life Sciences Ltd (Q3 FY26)
180.0 crore, up from Rs. Key concall takeaways from RPG Life Sciences Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- SMS Pharmaceuticals Ltd (Q3 FY26)
Q3FY26 Revenue from Operations: ₹210.45 crore, up 21% YoY (from ₹173.35 crore in Q3FY25) [Page 27] . Key concall takeaways from SMS Pharmaceuticals Ltd's Q3…
- Morepen Laboratories Ltd (Q3 FY26)
488 crores, up 17% from Q3 FY25 Rs. Key concall takeaways from Morepen Laboratories Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- Jubilant Pharmova Ltd (Q3 FY26)
2,143 Cr., up from Rs. Key concall takeaways from Jubilant Pharmova Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Innova Captab Ltd Q3 FY26 results?
Overall business growth targeted at 20%+ year-on-year (Vinay Lohariwala, Q3 FY26 call). - Jammu facility expected to drive 20%+ growth for the next 2-3 years with revenues ramping up from Rs. Innova Captab projects a sustained overall growth of 20%+ year-on-year at the organization level, driven significantly by ramp-up at the Jammu facility for the next 2-3 years. - Jammu facility revenues are expected to grow from Rs.
What is Innova Captab Ltd share price analysis?
Innova Captab Ltd currently shows a neutral. The stock trades at a P/E of 38.5 with a market cap of ₹5,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innova Captab Ltd planning capital expenditure?
Innova Captab is focused on ramping up the Jammu facility, which started commercial production in January 2025 and is expected to drive 20%+ overall business growth for the next 2-3 years. - Jammu facility has potential revenue capacity of Rs.
Keep Innova Captab Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.